Results per Page:
Value in Cancer Care Summit reimagines cancer care
Annual conference zeroes in on practical solutions for patient and provider pain points like burnout, symptom management and financial toxicity
Washington Research Foundation awards $5.2M to establish new clinical trials program
Funds will help develop ‘first-in-human’ trials for new therapeutics invented at Fred Hutch and Seattle Children’s
Lack of insurance, follow-ups undercut cancer screening wins
Large multi-institution PROSPR II study finds big gaps in access, timely care in cervical, colorectal and lung cancers across U.S.
Patient stories, provider advice mark invasive lobular breast cancer awareness event
Fred Hutch experts discuss ILC’s hormonal risk factors, screening recommendations and new research
Lived experience matters: patient engagement improves cancer care, research
Nearly 15 years in, Fred Hutch Patient and Family Engagement Program continues to inform care, expands to match advocates with researchers
Testing for hereditary cancers can be a lifesaver
Some people aren’t ready yet, while others believe ‘forewarned is forearmed’ when it comes to cancer-causing genetic variants
Are we ready for multi-cancer detection tests?
Blood-based cancer tests are coming, but questions about efficacy, reimbursement and diagnostic pathways are far from settled
Biomarkers, tumor markers and tumor boards: What cancer patients need to know
Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment
How do you measure your health? WHI comes up with two potent indicators
New studies using Women’s Health Initiative data highlight new ‘biomarkers’ to predict mortality risk and guide providers' care
Women’s Health Initiative: Research that keeps on giving
Three decades in, longstanding ‘team science’ study continues to provide answers to health issues facing older women
Pathways Symposium explores lack of access to cancer screening and care
Annual meeting of community partners, patient advocates and researchers tackle geographical, financial and other persistent barriers
Rare cancer researchers find promising target in fibrolamellar cancer
Fred Hutch’s TRACER initiative digs into aggressive liver cancer, hosts third rare cancer symposium
Dr. Filippo Milano receives inaugural Endowed Chair in Cord Blood Research
Unrestricted funding will help grow Fred Hutch’s Cord Blood Transplant Program so that ‘every patient has a donor’
Two doses of the HPV vaccine is all you need
Long-term immunity from human papillomavirus infections — and the deadly cancers they can drive — reached with just two jabs
Saying goodbye to a community partner and friend
Bridgette Hempstead, founder of Cierra Sisters and staunch health equity research advocate, remembered as a force for underserved patients
Navigating a brand-new cancer diagnosis
Fred Hutch nurse navigation program expands, reducing waiting time for new appointments and treatment
What’s new in breast cancer research? SABCS24 looks at ctDNA, AI and ‘right-sizing’ treatment
Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices
Polygenic risk scores and prostate cancer
New research shows genetic risk scores could help distinguish who can cut back on ‘active surveillance’
10 years in, HICOR’s efforts boost cancer care’s value
Fred Hutch’s Value in Cancer Care Initiative celebrates a decade of data and crucial collaborations between providers, payers and patients
Surviving and thriving with metastatic breast cancer
From financial toxicity to sexual health, experts break down survival strategies for patients and caregivers dealing with ‘mets’